Team 2

CARE Vessels: Autonomous Vascular Access Device

Team Members: James Crichton, Jacqueline Klier, Charmayne Seaton & Summer Suttell

Team Mentors: Kuei-Chun (Mark) Wang, PhD - SBHSE
Scott Beeman, PhD - SBHSE
James Bogert, MD - Dignity Health

YouTube Link: View the video link below before joining the zoom meeting

Zoom Link: https://asu.zoom.us/j/86816437748

Abstract

The current method clinicians use to gain vascular access is through a procedure known as the Seldinger Technique. This technique was introduced by Swedish radiologist in 1953 and has since been critiqued and modified. Decades later the technique is still a hassle to perform and still has routine complications including wrong vessel puncture, retention of guidewire in the vessel, inability to gain access to the vessel, and even wrong anatomic location of puncture. Our device integrates ultrasound into the existing Seldinger technique to allow clinicians to see which vessel they are entering which will as a result minimize their guess work and simplify the procedure. The autonomous vascular access device will identify femoral vessels using ultrasound, distinguish between artery and vein, and cannulate the desired vessel with a catheter of choice. The AVAD can then be removed, and the catheter can be used for volume infusion, blood draws, or interventional procedures. The device falls into the peripheral vascular market segment which is the part of the circulatory system that consists of the veins and arteries not in the chest or abdomen. This market segment currently has a compound annual growth rate (CAGR) of 8.7% and an annual revenue of roughly 8 billion dollars. This market segment is growing and is expected to keep growing due to the rapid growth in prevalence of peripheral vascular diseases and the growing geriatric population. Our target market is hospitals and healthcare clinics, but the device could be utilized in almost all clinical settings where arterial/central venous access is needed.